These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 2476322)
1. Correlative changes of serotonin and catecholamines with pharmacokinetic alterations of imipramine in rat brain. Sugita S; Kobayashi A; Suzuki S; Yoshida T; Nakazawa K Eur J Pharmacol; 1989 Jun; 165(2-3):191-8. PubMed ID: 2476322 [TBL] [Abstract][Full Text] [Related]
2. Effects of lithium on alterations of pharmacokinetics of imipramine and on the related changes of monoamines in rat brain. Yoshida T; Suzuki S; Sugita S; Kobayashi A; Nakazawa K Eur J Pharmacol; 1989 Dec; 173(2-3):143-9. PubMed ID: 2625134 [TBL] [Abstract][Full Text] [Related]
3. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain. Fujita K; Kobayashi A; Suzuki S; Nakazawa K Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048 [TBL] [Abstract][Full Text] [Related]
4. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments. Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178 [TBL] [Abstract][Full Text] [Related]
5. Androgen inhibits neurotransmitter turnover in the medial prefrontal cortex of the rat following exposure to a novel environment. Handa RJ; Hejna GM; Lorens SA Brain Res; 1997 Mar; 751(1):131-8. PubMed ID: 9098576 [TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine increases desipramine with changing the concentrations of monoamines, in the brain of rat given imipramine. Suzuki S; Yoshida T; Sugita S; Kobayashi A; Nakazawa K Eur J Pharmacol; 1993 Feb; 231(2):297-300. PubMed ID: 7681006 [TBL] [Abstract][Full Text] [Related]
7. Acute effects of nomifensine on in vivo uptake and metabolism of dopamine, noradrenaline and serotonin in the rat brain. Broch OJ Pharmacol Toxicol; 1987 Jan; 60(1):70-4. PubMed ID: 3562394 [TBL] [Abstract][Full Text] [Related]
8. Cocaine and regional brain monoamines in mice. Hadfield MG; Milio C Pharmacol Biochem Behav; 1992 Oct; 43(2):395-403. PubMed ID: 1438479 [TBL] [Abstract][Full Text] [Related]
9. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function. Singer S; Rossi S; Verzosa S; Hashim A; Lonow R; Cooper T; Sershen H; Lajtha A Neurochem Res; 2004 Sep; 29(9):1779-92. PubMed ID: 15453274 [TBL] [Abstract][Full Text] [Related]
10. The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes. Karoum F; Korpi ER; Chuang LW; Linnoila M; Wyatt RJ Eur J Pharmacol; 1986 Mar; 121(3):377-85. PubMed ID: 2422047 [TBL] [Abstract][Full Text] [Related]
11. [Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic]. Baba T; Takeda H; Lee JW; Takada K; Shibuya T Nihon Yakurigaku Zasshi; 1995 Mar; 105(3):177-85. PubMed ID: 7536700 [TBL] [Abstract][Full Text] [Related]
12. Region-specific decrease of dopamine and its metabolites in brains of mice given ergotamine. Filipov NM; Thompson FN; Tsunoda M; Sharma RP J Toxicol Environ Health A; 1999 Jan; 56(1):47-58. PubMed ID: 9923753 [TBL] [Abstract][Full Text] [Related]
13. Pineal melatonin and brain transmitter monoamines in CBA mice during chronic oral nicotine administration. Gäddnäs H; Pietilä K; Alila-Johansson A; Ahtee L Brain Res; 2002 Dec; 957(1):76-83. PubMed ID: 12443982 [TBL] [Abstract][Full Text] [Related]
14. Methyl bromide alters catecholamine and metabolite concentrations in rat brain. Honma T; Miyagawa M; Sato M Neurotoxicol Teratol; 1987; 9(5):369-75. PubMed ID: 2447477 [TBL] [Abstract][Full Text] [Related]
15. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases. Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376 [TBL] [Abstract][Full Text] [Related]
17. Effect of methylmercury exposure on different neurotransmitter systems in rat brain. Tsuzuki Y Toxicol Lett; 1982 Oct; 13(3-4):159-62. PubMed ID: 6183792 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Dunn AJ; Berridge CW Pharmacol Biochem Behav; 1987 Aug; 27(4):685-91. PubMed ID: 2443934 [TBL] [Abstract][Full Text] [Related]
19. Effects of neuropeptide Y on norepinephrine and serotonin metabolism in rat hypothalamus in vivo. Shimizu H; Bray GA Brain Res Bull; 1989 Jun; 22(6):945-50. PubMed ID: 2477116 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ; Whittington PE; Audsley AR Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]